Now livetag icon
Who's really winning the World Cup economy? The data is in!Get the snapshotbanner icon
Humabs

May 2026

Humabs Market Share Analysis for May 2026

meta home desc
Industry: N/A
Year Founded2004
Employees201 - 500
Annual Revenue$5M - $10M
humabs.com
Humabs
Humabs (including company regionals)
  • humabs.com
    humabs.com
See more website traffic and engagement information

Humabs Revenue up to May 2026 is 5M - 10M

revenue generated by Humabs top domains

Humabs top domains revenue over 3 years

Revenue for Humabs top domains


Total visits to Humabs's top domains

Understand Humabs market share and potential market reach.

Total visits last 3 months

No Data to Display

No Data to Display

Avg. visit duration in Humabs's top domains

Analyze Humabs engagement metrics.

Average visit duration last 3 months

No Data to Display

No Data to Display

Avg. pageviews on Humabs's top domains

See how Humabs keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

No Data to Display

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Humabs

These are the website technologies, by industry, used by Humabs top domains

Conversion & Analytics (2)

Google Analytics

Google Analytics

Mobile (2)

Meta Viewport

Meta Viewport

Advertising (1)

PubMatic

PubMatic

Audio Video Media (1)

Vimeo

Vimeo

More Technologies

3

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Humabs

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsVir Biotechnology, Inc. partners with Humabs.October 18, 2017 - Vir Biotechnology, Inc. today announced agreements with Humabs BioMed SA, Alnylam Pharmaceuticals, Inc. (NASDAQ: ALYN), and Visterra, Inc., as well as four leading academic research institutions.

See all Humabs signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.